Genetically engineered glutaminase and its use in antiviral and anticancer therapy
AssigneeME Medical Enzymes AG
InventorsJoseph Roberts, Thomas MacAllister, Natarajan Sethuraman, Abbie Freeman
Life of this patent
Estimating the term…
Abstract
DNA encoding a therapeutically suitable glutaminase has been molecularly cloned. This allows one to obtain a polypeptide which is a therapeutically suitable glutaminase free of contaminating endotoxin. It has been found that this polypeptide is a potent anti-viral agent and when coupled to an anti-tumor monoclonal antibody is a potent anti-cancer agent. The gluatminase of the present invention is particularly useful for treating lung, breast and colon cancer cells and in the treatment of HIV-infected cells.
Claims11
A cell-free preparation of a therapeutically suitable glutaminase which is free of Pseudomonas endotoxin.
Dependencies are inferred from the claim text.